Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
2
×
san francisco blog main
san francisco top stories
acute migrane
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
bain capital
bausch health
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
crispr therapeutics
crispr-cas9
deals
denali therapeutics
desmoid tumor
detroit blog main
detroit top stories
dihydroergotamine
dihydroergotamine mesylate
eidos therapeutics
estradiol
f-star gamma
fda
food and drug administration
What
biotech
days
2
×
drug
2
×
activity
ahead
ambien
american
annual
asco
attendees
attention
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
companies
dog
expanding
firm
focus
hasn’t
home
ipo
ipos
key
kicks
leading
line
meeting
migraine
oncology
oncology’s
pfizer
place
potential
prep
Language
unset
Current search:
days
×
drug
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More